GERD

Gastroenterology·MeSH: Gastroesophageal Reflux

16 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
dexlansoprazole	Mylan II B.V. (MYL)
esomeprazole magnesium	Mylan II B.V. (MYL)
esomeprazole magnesium	SUNSET ISLAND GROUP (SUN)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
esomeprazole magnesium	LANNETT CO INC (LCI)
famotidine	Avita Medical Inc. (RCEL)
famotidine	Seagen Inc. (SGEN)
famotidine	ENGENE HOLDINGS INC. (ENGN)
famotidine	SUNSET ISLAND GROUP (SUN)
famotidine	Miromatrix Medical Inc. (MIRO)
famotidine	Mersana Therapeutics, Inc. (MRSN)
inFoods® (IBS)	BIOMERICA INC (BMRA)
pantoprazole	EXELIXIS, INC. (EXEL)
pantoprazole	SUNSET ISLAND GROUP (SUN)
VOQUEZNA	Phathom Pharmaceuticals, Inc. (PHAT)

Unknown(1)

Drug	Company
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA)

BioSniper tracks 16 drugs in development for GERD across 11 companies.

There are 1 clinical trial targeting GERD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.